Urinary Tract Infections

A natural fruit concentrate in chewable tablets can help bladder infections and be derived from urinary tract meet each and are often very painful and uncomfortable. If left untreated it can rise and cause damage to the kidneys. Women are most frequently affected by urinary tract infections and cystitis. This is due to the anatomical conditions in the urogenital tract of the woman and the short urethra, through which the pathogen easily can Ascend, to establish itself in the lining of the bladder. This set the Agent prevents usually an intact immune system and a strong bladder mucosa. But not always. The frequently recurring bladder infections can occur.

“Researchers have found that the American relatives of our local Cranberries contain a substance, the docking” of the bacteria in the lining of the bladder can effectively suppress. This Cranberry referred to Cranberry extracts have in clinical trials as a very effective in women with recurrent cystitis and urinary tract infections proved to be. The number of infections was significantly reduced in these women. UroVitum chew/suck chewable tablets are designed for the complementary treatment of recurrent urinary tract infections (cystitis) women. They are based on clinical studies for the treatment of urinary tract infections and contain 350 mg Cranberry concentrate per chew/suck tablet. The chewing / sucking tablets are equipped with savory cranberry aroma and pleasant to eat. That makes them so unique compared to the very sour cranberry juice. The tablets are clearly preferred by patients because they taste just good and fast work.

UroVitum offers the chance to get rid of the annoying urinary tract infections. In the studies is a revenue period of years. UroVitum (PZN 0765808) is available to 24.90 in pharmacies or good health centers for a month. Due to the unique composition of the products of Navitum Pharma not by other, seemingly similar products are interchangeable.

This entry was posted in News and tagged , . Bookmark the permalink. Follow any comments here with the RSS feed for this post. Both comments and trackbacks are currently closed.